After infection with Klebsiella pneumoniae, which is the respiratory Gram-negative bacterium that usually causes pneumonia, PPARγ agonists such as pioglitazone reduced proinflammatory cytokine and myeloperoxidase levels, bacterial growth in lung tissues, and bacterial dissemination to distant organs [105]. Here, PPARG is linked to infection.